Launch One Acquisition Corp. 8-K

What Happened

• Launch One Acquisition Corp. announced that, effective January 30, 2026, it and the other parties mutually terminated the Business Combination Agreement (BCA) with Minovia Therapeutics Ltd. The original BCA was dated June 25, 2025 and had been amended on August 12, 2025; September 4, 2025; September 26, 2025; and January 6, 2026.
• The Termination and Release Agreement (entered the same day) formally ends the BCA and all defined Ancillary Agreements, and each party released the others from liabilities and damages related to the transaction documents and the proposed transaction. Parties to the termination included Launch One, its sponsor (Launch One Sponsor LLC as SPAC Representative), Minovia, the Seller Representative (Natalie Yivgi‑Ohana), Mito US One Ltd. (Pubco) and Mito Sub Israel Ltd. (Merger Sub).

Key Details

• Termination date: January 30, 2026.
• Original BCA date: June 25, 2025; amendments on Aug 12, 2025; Sept 4, 2025; Sept 26, 2025; Jan 6, 2026.
• All Ancillary Agreements automatically terminated and mutual releases of claims were executed.
• The Termination and Release Agreement is attached as Exhibit 10.1 to the 8‑K. The company and its sponsor say they intend to seek alternative ways to consummate an initial business combination.

Why It Matters

• For investors, this means the previously announced SPAC business combination with Minovia will not proceed; the legal agreements that governed that deal are no longer in effect.
• The company remains a SPAC seeking an initial business combination, but the timing, partner and structure are now uncertain; investors should monitor future filings for any new deal announcements or impacts on the SPAC’s timeline and capital structure.